HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme
Conditions: Papillomavirus Infections; Early Detection of Cancer; Cervix Cancer; Self-Examination Interventions: Device: Directly mailed self-sampling kit to collect a vaginal sample; Device: Mailed self-sampling kit to collect a vaginal sample after opt-in prodecure; Diagnostic Test: Standard of care - screening in a clinical setting Sponsors: Universidade do Porto; Unidade de Sa úde Familiar de Garcia de Orta, Porto; Unidade de Saúde Familiar da Prelada, Porto; Unidade de Saúde Familiar de Cedofeita, Porto; Instituto Portugues de Oncologia, Francisco Gentil, Porto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.
Conditions: Breast Cancer; Chemotherapy Effect; Diffusion Weighted MRI; PET Imaging; Multiparametric Magnetic Resonance Imaging Interventions: Radiation: Whole body 18F-FDG Positron Emission Tomography Sponsors: National Taiwan University Hospital; Ministry of Science and Technology, Taiwan Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Adverse Events for Free Flap Surgery in Head and Neck Cancer
Conditions: Surgical Flaps; Flap Failure Risk Factors; Hematoma Risk Factors; Thrombosis Risk Factors Interventions: Procedure: Free Flap surgery Sponsors: Kaohsiung Medical University; Kaohsiung Medical University Chung-Ho Memorial Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Neo-Sequence 2 ：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC
Conditions: Gastric Cancer; Diffuse Type Carcinoma Interventions: Drug: Albumin paclitaxel+SOX+BEV+ PD-1 monoclonal antibody therapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
LapEmerge trial: study protocol for a laparoscopic approach for emergency colon resection —a multicenter, open label, randomized controlled trial
DiscussionPrevious studies cautiously recommend wider use of laparoscopy in emergency colorectal resections, but all earlier reports are retrospective, are mostly single-center studies, and have limited numbers of patients. Laparoscopy may involve some unpredictable risks that have not yet been reported because of the infrequent use of the techniqueded to assess the safety of laparoscopy as well as the advantages and disadvantages of open compared with laparoscopic emergency surgery.Trial registrationTrial registration number: ClinicalTrials.gov NCT05005117. Registered on August 12, 2021. (Source: Trials)
Source: Trials - April 17, 2024 Category: Research Source Type: clinical trials
Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas
Conditions: Intracranial Germ Cell Tumor; Childhood Central Nervous System Germinoma Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy; Drug: Carboplatin; Drug: Etoposide; Radiation: Intensity-Modulated Radiation Therapy Sponsors: Children ' s Oncology Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
10-year Retrospective Study of Oral and Maxillofacial Squamous Cell Carcinoma
Conditions: HNSCC; AI; Radiomic; MRI Interventions: Diagnostic Test: The Resnet50 deep learning (DL) model Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
Conditions: Squamous Cell Carcinoma of Head and Neck Interventions: Procedure: App Usage; Other: Standard of Care Sponsors: University of Erlangen-N ürnberg Medical School Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma
Conditions: Lymphopenia Sponsors: Chang Gung Memorial Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, and Sabestomig in HNSCC
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Biological: Rilvegostomig; Biological: Volrustomig; Biological: Sabestomig; Biological: Pembrolizumab Sponsors: Presage Biosciences; AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
Conditions: Pancreatic Cancer Resectable Interventions: Drug: Huaier granule; Drug: chemotherapy drugs Sponsors: Health Science Center of Xi ' an Jiaotong University; LinkDoc Technology (Beijing) Co. Ltd.; Huazhong University of Science and Technology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Conditions: Uterine Serous Carcinoma; Uterine Carcinoma; Uterine Cancer Interventions: Drug: Azenosertib Sponsors: Joyce Liu, MD; National Cancer Institute (NCI); Zentalis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Clinical Efficacy of 125I Brachytherapy Combined With Anlotinib in Radioiodine Refractory Thyroid Carcinoma Patients
Conditions: Thyroid Neoplasms Interventions: Combination Product: Iodine-125 brachytherapy combine with Anlotinib Sponsors: Jiangxi Provincial Cancer Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC
Conditions: Neuroendocrine Carcinoma; Non-small Cell Lung Cancer; Histology Transformation Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
PRORAD-5 PROstate RADiation in 5 Fractions: Phase Ib Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer Interventions: Device: Stereotactic Body Radiation Therapy Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
